DNA Dynamics, Inc. DNAD Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
DNA Dynamics, Inc. DNAD Company Overview 

Stock Message Board http://investorshangout.com/search?q=DNAD&...mp;yt1=Go!

DNA Dynamics, Inc. DNAD Current Price and Quotes
0.0002
Previous Close
0.0002
Open
0.0001

Daily Range
0.0002 - 0.0001
52wk Range
0.07 - 0.0001

Volume
14,278,219
Dividend
N/A

Average Vol (3m)
46,202,953
Yield
N/A

DNA Dynamics, Inc. DNAD

Company Verified Profile
Company Information
Super Sonic House
23 Adelaide Road
Leamington Spa CV31 3PD
United Kingdom

Website: http://www.dnadynamics.net
Phone: 44-1926-460180
Email: info@dnadynamics.net
Find us on:      

DNA Dynamics, Inc. DNAD
DNAD is a publisher and developer of games and Apps for mobile and tablet devices through it's wholly owned subsidiaries DNA Interactive Limited and DNA Studios Limited. Games include 'The Naked Gun:ICUP', 'Warheads:Medieval Tales' and 'Legacy:Mystery Mansion' amongst many others.

DNA Dynamics, Inc. DNAD
Financial Reportings and Disclosures
Reporting Status Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001086313
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 6794 - Patent owners and lessors
Business Status Development Stage Company a/o May 20, 2009
Incorporated In: DE, USA
Year of Inc. 1981
Employees 10 a/o Jun 01, 2012
Company Officers/Contacts
David Lovatt President, CEO, Corporate Secretary
Company Directors
Ed Blincoe Non-Executive Chairman
Company Notes
Formerly=Multi-Tech Corp. until 8-06
Service Providers
Auditor/Accountant
MaloneBailey, LLP
10350 Richmond Ave.
Suite 800
Houston, TX, 77042
United States

Legal Counsel
John D. Thomas P.C.
11650 South State Street
Draper, UT, 84020
United States

Law Office of Thomas Russell
3700 Campus Drive
Newport Beach, CA, 92660
United States

Investor Relations Firm
Not Available

DNA Dynamics, Inc. DNAD
DNAD Security Details
Share Structure
Market Value1 $1,728,819 a/o Sep 04, 2013
Shares Outstanding 8,644,095,988 a/o Jul 31, 2013
Float 644,095,988 a/o Jul 31, 2013
Authorized Shares 9,000,000,000 a/o Jul 31, 2013
Par Value  0.001
Shareholders
Shareholders of Record 46 a/o Mar 31, 2013
Security Notes
Capital Change=shs decreased by 1 for 100 split Pay date=08/04/2006.
Capital Change=shs decreased by 1 for 500 split. Ex-date=01/30/2013.
Short Selling Data
Short Interest 0 (-100%)
Jul 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Registrar and Transfer Co.

DNA Dynamics, Inc. DNAD Recent News


Jun 12, 2013 DNA Dynamics, Inc. Signs With New Outsource Partner


DNA Dynamics, Inc. DNAD Financials
DNAD

DNAD DNA Dynamics, Inc. Research DD Guide

DNAD DNA Dynamics, Inc. Stock Message Board http://investorshangout.com/search?q=DNAD&...mp;yt0=Go!
DNAD DNA Dynamics, Inc. Stock Quote http://www.otcmarkets.com/stock/DNAD/quote
DNAD DNA Dynamics, Inc. Stock Chart http://www.otcmarkets.com/stock/DNAD/chart
DNAD DNA Dynamics, Inc. Company Info http://www.otcmarkets.com/stock/DNAD/company-info
DNAD DNA Dynamics, Inc. Recent News http://www.otcmarkets.com/stock/DNAD/news
DNAD DNA Dynamics, Inc. Financials http://www.otcmarkets.com/stock/DNAD/financials
DNAD DNA Dynamics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/DNAD/filings
DNAD DNA Dynamics, Inc. Short Sales http://www.otcmarkets.com/stock/DNAD/short-sales
DNAD DNA Dynamics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/DNAD/insider-transactions
DNAD DNA Dynamics, Inc. Research Reports http://www.otcmarkets.com/stock/DNAD/research
DNAD DNA Dynamics, Inc. Summary http://finance.yahoo.com/q?s=DNAD
DNAD DNA Dynamics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=DNAD+Historical+Prices
DNAD DNA Dynamics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=DNAD
DNAD DNA Dynamics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=DNAD+Basic+Chart
DNAD DNA Dynamics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=DNAD+Basic+Tech.+Analysis
DNAD DNA Dynamics, Inc. Headlines http://finance.yahoo.com/q/h?s=DNAD+Headlines
DNAD DNA Dynamics, Inc. Press Releases http://finance.yahoo.com/q/p?s=DNAD+Press+Releases
DNAD DNA Dynamics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=DNAD+Profile
DNAD DNA Dynamics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=DNAD+Key+Statistics
DNAD DNA Dynamics, Inc. Industry http://finance.yahoo.com/q/in?s=DNAD+Industry
DNAD DNA Dynamics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=DNAD+Major+Holders
DNAD DNA Dynamics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=DNAD+Insider+Transactions
DNAD DNA Dynamics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=DNAD+Insider+Roster
DNAD DNA Dynamics, Inc. Income Statement http://finance.yahoo.com/q/is?s=DNAD
DNAD DNA Dynamics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=DNAD
DNAD DNA Dynamics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=DNAD+Cash+Flow&annual
DNAD DNA Dynamics, Inc. Nasdaq http://www.nasdaq.com/symbol/DNAD
DNAD DNA Dynamics, Inc. Market Watch http://www.marketwatch.com/investing/stock/DNAD
DNAD DNA Dynamics, Inc. Bloomberg http://www.bloomberg.com/quote/DNAD:US
DNAD DNA Dynamics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=DNAD
DNAD DNA Dynamics, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=DNAD
DNAD DNA Dynamics, Inc. Barchart http://www.barchart.com/quotes/stocks/DNAD
DNAD DNA Dynamics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=DNAD
DNAD DNA Dynamics, Inc. Investopedia http://www.investopedia.com/markets/stocks/DNAD/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading